NO148454C - Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater

Info

Publication number
NO148454C
NO148454C NO784382A NO784382A NO148454C NO 148454 C NO148454 C NO 148454C NO 784382 A NO784382 A NO 784382A NO 784382 A NO784382 A NO 784382A NO 148454 C NO148454 C NO 148454C
Authority
NO
Norway
Prior art keywords
tiazolidine
preparation
therapeutically active
dione derivatives
analogy procedure
Prior art date
Application number
NO784382A
Other languages
English (en)
Norwegian (no)
Other versions
NO784382L (no
NO148454B (no
Inventor
Dennis Claude Bigg
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7739559A external-priority patent/FR2413381A1/fr
Priority claimed from FR7833244A external-priority patent/FR2442232A2/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO784382L publication Critical patent/NO784382L/no
Publication of NO148454B publication Critical patent/NO148454B/no
Publication of NO148454C publication Critical patent/NO148454C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO784382A 1977-12-29 1978-12-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater NO148454C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7739559A FR2413381A1 (fr) 1977-12-29 1977-12-29 Derives de thiazolidinedione et leur application en therapeutique
FR7833244A FR2442232A2 (fr) 1978-11-24 1978-11-24 Derives de thiazolidinedione-2,4 et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO784382L NO784382L (no) 1979-07-02
NO148454B NO148454B (no) 1983-07-04
NO148454C true NO148454C (no) 1983-10-12

Family

ID=26220372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO784382A NO148454C (no) 1977-12-29 1978-12-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater

Country Status (17)

Country Link
US (1) US4349683A (es)
EP (1) EP0002978B1 (es)
JP (1) JPS6011908B2 (es)
AR (1) AR223160A1 (es)
AT (1) AT370098B (es)
AU (1) AU517221B2 (es)
CA (1) CA1107740A (es)
DE (1) DE2862059D1 (es)
DK (1) DK149429C (es)
ES (1) ES476408A1 (es)
FI (1) FI68819C (es)
GR (1) GR65312B (es)
IE (1) IE47902B1 (es)
IL (1) IL56304A (es)
NO (1) NO148454C (es)
NZ (1) NZ189300A (es)
PT (1) PT68991A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPH0750560B2 (ja) * 1981-05-09 1995-05-31 ヤマハ株式会社 ディジタル集積回路装置
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
EP0715853A1 (en) * 1991-01-10 1996-06-12 Transcend Therapeutics, Inc. Use of glutathione esters for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
KR20150068829A (ko) * 2013-12-12 2015-06-22 삼성전자주식회사 알킬 암모늄염 화합물을 포함하는 유도 용질

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1435004A (fr) * 1965-02-04 1966-04-15 Sobio Lab Dérivés de thiazolidine-dione-2, 4- et procédé de préparation

Also Published As

Publication number Publication date
EP0002978A3 (en) 1979-07-25
IL56304A0 (en) 1979-03-12
IE47902B1 (en) 1984-07-25
ATA936678A (de) 1982-07-15
FI783995A (fi) 1979-06-30
FI68819C (fi) 1985-11-11
JPS6011908B2 (ja) 1985-03-28
US4349683A (en) 1982-09-14
FI68819B (fi) 1985-07-31
AR223160A1 (es) 1981-07-31
DE2862059D1 (en) 1982-11-11
CA1107740A (en) 1981-08-25
NO784382L (no) 1979-07-02
AT370098B (de) 1983-02-25
DK149429C (da) 1987-03-09
NZ189300A (en) 1980-05-27
AU517221B2 (en) 1981-07-16
DK149429B (da) 1986-06-09
EP0002978B1 (fr) 1982-10-06
GR65312B (en) 1980-08-02
EP0002978A2 (fr) 1979-07-11
DK582578A (da) 1979-06-30
JPS5498758A (en) 1979-08-03
ES476408A1 (es) 1979-04-01
NO148454B (no) 1983-07-04
IE782561L (en) 1979-06-29
AU4296178A (en) 1979-07-05
PT68991A (fr) 1979-01-01
IL56304A (en) 1982-02-28

Similar Documents

Publication Publication Date Title
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO147562C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO149065C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler